CD24 and breast carcinoma: In a recent study related to our work, an identical epigenetic state in the promoter region of the CD24 gene has been observed between interconvertible CD24-positive and negative subsets of CD44+ breast cancer cells [50], indicating that transcriptional permissiveness is a general phenomenon.